Covid-19: FDA Issues EUA for Regeneron’s Monoclonal Antibody Tx
Casirivimab/imdevimab authorized for ’mild to moderate’ Covid-19 Casirivimab and imdevimab, a...
Breaking Infectious Disease
Covid-19: FDA Grants EUA for First At-Home Self-Test Kit
Patients can test themselves and get results in 30 minutes or less WASHINGTON —The FDA issued an...
Covid-19: Military’s Mitigation Strategies Appear Successful
Few serious cases among outbreaks More than three-quarters (77%) of the 1,271 crew members...
